IDEXX Laboratories, Inc. (IDXX)

Market Cap	33.53B
Revenue (ttm)	3.84B
Net Income (ttm)	866.24M
Shares Out	81.88M
EPS (ttm)	10.36
PE Ratio	39.49
Forward PE	34.97
Dividend	n/a
Ex-Dividend Date	n/a

Volume	155,236
Open	406.83
Previous Close	409.03
Day's Range	404.36 - 409.48
52-Week Range	398.50 - 583.39
Beta	1.37
Analysts	Buy
Price Target	539.63 (+31.78%)
Earnings Date	Feb 3, 2025

About IDXX

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnos...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Jun 21, 1991
• Employees: 11,000
• Stock Exchange: NASDAQ
• Ticker Symbol: IDXX
• Website: https://www.idexx.com

Financial Performance

In 2023, IDEXX Laboratories's revenue was $3.66 billion, an increase of 8.72% compared to the previous year's $3.37 billion. Earnings were $845.04 million, an increase of 24.44%.

Analyst Forecast

According to 8 analysts, the average rating for IDXX stock is "Buy." The 12-month stock price forecast is $539.63, which is an increase of 31.78% from the latest price.

Price Target

$539.63

(31.78% upside)

Analyst Consensus: Buy